Objective :
Performance evaluation of new assets on the basis of Lead and Lag KPIs
Problem Statement:
A global pharmaceutical company aimed to monitor the performances of its wide variety of newly launched oncology products based on Lead and Lag KPIs on a monthly, quarterly, and yearly basis in Locally operating countries (LOCs).
Our Methodology:
- Lead KPIs: Sales/Volume/Patient data/Patient share/Market share across the lines etc.
- Lag KPIs: Awareness, Share of Voice, Coverage, Market access, Duration of treatment, Doses, etc.
- Database creation with various LOC teams for timely availability of required data
- Sanity check of the large set of information before publishing on the dashboard for a high-level review
Results:
- A web-based, interactive KPI dashboard covering all the suggested visualization with the functionality of providing a monthly executive summary
- Timely information to provide performance feedback to LOCs just in time
- Evolution index helped to compare the performances of individual countries
- Good and bad performing brands/countries in the set of different brands/countries
Our Related Services
Asset Prioritization
Develop R&D strategy with reliable analysis of your asset group and come up focused list of prioritized assets.
Market Assessment
Achieve Breakthroughs with all-encompassing Market Outlook Research
Sample Visuals
Transform your business with our case study. Download now and achieve your goals!
Related Insights
In-Licensing Opportunity
A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset...
View CaseOut-Licensing Opportunity
A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr...
View CaseGo-To-Market Strategy
A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe...
View Case